Laurel Bristow

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

D. Douek, J. Wrammert, Sucheta Godbole, 2021, bioRxiv.

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Madeleine K. D. Scott, B. Pulendran, P. Khatri, 2020, Science.

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

D. Douek, J. Wrammert, Sucheta Godbole, 2022, Cell Reports Medicine.